Facts about the share
Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and it’s ADRs are listed on the New York Stock Exchange. Please refer to the table below.
|Stock exchange||Listing type||Stock symbol/name||Reuters ticker|
|Copenhagen||Listed shares||DK0060534915 (ISIN)||NVOb.CO|
Novo Nordisk’s share capital is DKK 550,000,000, which is divided into an A share capital of nominally DKK 107,487,200 and a B share capital of nominally DKK 442,512,800. Novo Nordisk’s A shares are non-listed shares and held by Novo A/S (based in Gladsaxe, Denmark), a private limited Danish company which is 100% owned by the Novo Nordisk foundation (based in Gentofte, Denmark). The B shares are traded in units of DKK 0.2. The ratio of Novo Nordisk B shares to ADR's is 1:1. The B shares are issued to the bearer, but may upon request be registered in the holder's name in Novo Nordisk's register of shareholders. Each holding of DKK 0.2 of A share capital carries ten times as many votes votes as each holding of DKK 0.2 of B share capital. Each A-share carries 200 votes, whereas each B-share carries 20 votes.
|Average number of outstanding shares in 2013 (million)|
|Average number of shares outstanding (excluding treasury shares)||2679.4|
|Average number of options in the money outstanding||14.3|
|Average number of shares outstanding including options in the money||2693.6|
The average number of shares outstanding is the total number of shares excluding Novo Nordisk’s holding of own shares.
As Novo Nordisk B shares are in bearer form, no official record of shareholders exists.
Based on the available sources of information on the company’s shareholders, it is estimated that Novo Nordisk’s shares at the end of 2013 were distributed as shown in the table below.